Crystal structure of human GPX4 in complex with GXpep-2 | | monomer | 29-197 | 1×GOL; |
Assess |
Crystal structure of human GPX4-U46C in complex with LOC1886 | | monomer | 30-197 | 2×LBI; 1×EDO; |
Assess |
wildtype form (apo) of human GPX4 with Se-Cys46 | | monomer | 32-197 | 2×CL; 2×EOH; 1×GOL; |
Assess |
Crystal structure of human GPX4-U46C-R152H in complex with ML162 | | monomer | 32-197 | 1×L9C; 2×EDO; |
Assess |
Crystal structure of human GPX4 in complex with GXpep-1 | | monomer | 33-197 | 2×GOL; |
Assess |
High resolution structure of selenocysteine containing human GPX4 | | monomer | 33-197 | 3×CL; |
Assess |
Crystal structure of human GPX4-U46C with oxidized Cys-46 | | monomer | 33-197 | 2×ACT; |
Assess |
Human GPX4 in complex with covalent Inhibitor ML162 (S enantiomer) | | monomer | 33-197 | 1×G9N; 1×SO4; 1×EDO; 2×DMS; |
Assess |
Crystal structure of the Selenocysteine to Cysteine Mutant of human phospholipid hydroperoxide glut… | | monomer | 33-197 | |
Assess |
Crystal structure of human R152H GPX4-U46C | | monomer | 33-197 | 1×SCN; |
Assess |
Crystal structure of human GPX4-U46C mutant K48L | | monomer | 33-197 | |
Assess |
Crystal structure of human GPX4-U46C in complex with MAC-5576 | | monomer | 33-197 | 2×LW1; |
Assess |
Crystal structure of human GPX4-U46C | | monomer | 34-197 | 2×PO4; 2×GOL; 1×EDO; |
Assess |
Crystal structure of human GPX4-U46C mutant K48A | | monomer | 34-197 | 1×SCN; |
Assess |
Crystal structure of human GPX4-U46C-R152H in complex with TMT10 | | monomer | 34-197 | 1×8NB; 1×SCN; |
Assess |
Crystal structure of human GPX4 in complex with GXpep-3 | | monomer | 34-197 | 1×GOL; |
Assess |
Crystal structure of human GPX4-U46C-R152H in complex with CDS9 | | monomer | 34-197 | 1×L9U; 1×SCN; |
Assess |
Crystal structure of human GPX4-U46C in complex with RSL3 | | monomer | 35-197 | 1×L8X; |
Assess |
Crystal structure of the selenocysteine to glycine mutant of human glutathione peroxidase 4(GPX4) | | monomer | 36-197 | 1×CL; |
Assess |